Home › Reset Therapeutics, Inc. Establishes Research Collaboration With Alkermes For Discovery And Development Of Novel Orexin Modulators
 

Keywords :   


Reset Therapeutics, Inc. Establishes Research Collaboration With Alkermes For Discovery And Development Of Novel Orexin Modulators

2016-03-30 06:05:57| drugdiscoveryonline Home Page

Reset Therapeutics, Inc., announced recently a collaboration with an affiliate of Alkermes plc for the discovery, development and commercialization of novel orexin receptor modulators from Reset’s drug discovery platform

Tags: research development novel collaboration

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.05ELF Beauty Teams with Billie Jean King to Change the Board Game to Support Inclusivity
05.05Target Faces Lawsuit Over Sunscreen Coral Bleaching Claims
05.05Goops Latest Launch & Hain Celestial Streamlines Portfolio
05.05The Summer of Sister Golden Hair
05.05Persil Laundry Detergent Rebrands
05.05Weekly Recap: Carefree Adds Pads to Lineup, Soft N Dry Secures Private Label Sales Network ...
05.05How Brexit is not 'done' for Northern Ireland
05.05Is Zimbabwe zigzagging into further currency chaos?
More »